Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
High-grade AV Block Due to Lyme Disease
Author(s): Vivek Bhat , Thomas Fretz , Hannah Shideler , et al Added: 1 week ago

Electrophysiology & Arrhythmia
HRS 25: The BIO-LIBRA Study
Author(s): Valentina Kutyifa Added: 10 months ago
HRS 2025 - Contemporary outcomes from implantable devices in non-ischemic cardiomyopathy patients observed more advanced heart failure symptoms in women at the time of ICD implantation, and white women implanted with CRT-D devices had significantly lower ventricular arrhythmia events compared to men of all races and black women implanted with both device types.Dr Valentina Kutyifa (University of… View more

Demographic

Electrophysiology & Arrhythmia
TCT 24: The ECLIPSE Trial
Author(s): Ajay J Kirtane Added: 1 year ago
TCT Conference 2024 - Routine use of orbital atherectomy system (OAS) did not improve minimal stent area (MSA) or target vessel failure (TVF) at one year compaared to conventional balloon angioplasty.Dr Ajay J Kirtane (Columbia University Medical Center and New York-Presbyterian Hospital, New York, US) joins us onsite at TCT Conference to discuss the findings from ECLIPSE (NCT03108456; Abbott… View more

Intervention
Author(s): Finn Gustafsson Added: 1 year ago
HFA 24 - Dr Finn Gustafsson (Rigshospitalet, DK) joined us onsite at the Heart Failure Association Congress to discuss the findings from a subanalysis of the ARIES HeartMate 3 study (NCT04069156).ARIES HM3 is a prospective, randomised, double-blinded, placebo-controlled clinical investigation into heart failure (HF) patients treated with the ARIES HeartMate 3 pump, who were treated with two… View more

Anticoagulation

Heart Failure
NOAC Monotherapy Noninferior to Combo Therapy Post-DES
Added: 2 weeks ago Source:  Arrhythmia Academy
In atrial fibrillation (AF) patients post one-year drug-eluting stent (DES) implantation, non–vitamin K antagonist oral anticoagulant (NOAC) was shown to be noninferior to NOAC plus clopidogrel combination therapy.¹ Current guidelines recommend NOAC monotherapy in this patient population, but supporting evidence has been limited.²MethodologyThe ADAPT AF-DES trial was a multicenter, randomised,… View more

Anticoagulation

Electrophysiology & Arrhythmia
HFSA 25: The INTEGRA-D Trial
Author(s): Nir Uriel Added: 4 months ago
HFSA 25 - CCM-D was associated with successful defibrillation and symptom improvement in patients with HFrEF at 6 months in the INTEGRA-D Trial.Dr Nir Uriel (NewYork-Presbyterian, Columbia University Irving Medical Center, US) joins us to discuss findings from the Integra-D trial, evaluating a novel implantable device that provides both cardiac contractility modulation and defibrillation… View more

Heart Failure
Hafiza Khan
Research Area(s) / Expertise:

Atrial Arrhythmias

Pacing, Defibrillators & Cardiac Resynchronisation Therapy

Electrophysiology & Arrhythmia

 Job title: Cardiac Electrophysiologist
DrHafiza Khan is a Cardiac Electrophysiologist at Baylor Scott & White Arrhythmia Management. She is a graduate of UCLA School of Medicine, Board Certified in both Cardiovascular disease as well as Electrophysiology, and has been in practice for over 18 years. In addition to performing catheter ablation for cardiac arrhythmias, implantation of pacemakersand implantable cardiac defibrillators,… View more
Harry G Mond
Job title: Associate Professor
DrMond is an Associate Professor at both Melbourne and Monash Universities in Victoria, Australia. He has been performing pacemaker implantation since 1970 at the Royal Melbourne Hospital. Dr Mond was a foundation committee member of NASPeXAM (IBHRE). Dr Mond has retired from pacemaker implantation, but is still responsible for the pacemaker clinic at the Royal Melbourne Hospital. He has authored… View more
Sandrine Venier
​Dr Sandrine Venier is a cardiologist and electrophysiologist at CHU Grenoble Alpes, France. She specialises in cardiac electrophysiology, including catheter ablation, pacemaker implantation, and implantable cardioverter-defibrillators. Her research interests encompass atrial fibrillation management, cardiac electrophysiology, and electrocardiography. View more
ACC 24 Late-Breaker Discussion: The RELIEVE-HF Trial
Author(s): Harriette Van Spall , Gregg Stone Added: 1 year ago
ACC 2024 — Late-breaker host Dr Harriette Van Spall (McMaster University, CA) welcomes Principal Investigator Dr Gregg Stone (Icahn School of Medicine at Mount Sinai, New York, NY, US) to discuss the REducing Lung congestIon Symptoms Using the v-wavE Shunt in adVancEd Heart Failure (NCT03499236) (V-Wave Ltd).The RELIEVE-HF trial aims to assess the safety and efficacy of a new device, the V-Wave… View more

Heart Failure